Table 2.
Microorganisms isolated from the 1048 culture-positive infected patients
| LowABR countries (n = 196) | HighABR countries (n = 852) | P-value | |
|---|---|---|---|
| Pathogen, n (%) | |||
| S. aureus | 32 (16.3) | 137 (16.1) | 0.993 |
| MRSA | 2 (1.0) | 69 (8.1) | <0.001 |
| MSSA | 30 (15.3) | 70 (8.2) | 0.002 |
| S. epidermidis | 18 (9.2) | 117 (13.7) | 0.087 |
| S. pneumoniae | 14 (7.1) | 39 (4.6) | 0.139 |
| Enterococci | 31 (15.8) | 92 (10.8) | 0.049 |
| G+, others | 20 (10.2) | 48 (5.6) | 0.019 |
| E. coli | 36 (18.4) | 128 (15.0) | 0.245 |
| Enterobacteriaceae | 10 (5.1) | 52 (6.1) | 0.592 |
| Klebsiella | 21 (10.7) | 92 (10.8) | 0.973 |
| P. aeruginosa | 27 (13.8) | 172 (20.2) | 0.039 |
| Acinetobacter spp | 5 (2.6) | 130 (15.3) | <0.001 |
| ESBL-producing | 4 (2.0) | 10 (1.2) | 0.340 |
| G-, others | 37 (18.9) | 136 (16.0) | 0.322 |
| Anaerobes | 15 (7.7) | 22 (2.6) | <0.001 |
| Bacteria, others | 3 (1.5) | 12 (1.4) | 0.897 |
| Candida | 45 (23.0) | 156 (18.3) | 0.136 |
| Aspergillus | 1 (0.5) | 8 (0.9) | 0.557 |
| Fungi, others | 5 (2.6) | 6 (0.7) | 0.022 |
| Parasites | 4 (2.0) | 6 (0.7) | 0.083 |
| Organisms, others | 12 (6.1) | 19 (2.2) | 0.004 |
MRSA, methicillin-resistant S. aureus; MSSA, methicillin-sensitive S. aurues; G+, Gram positive; ESBL, extended-spectrum-beta-lactamase; G-, Gram negative.